Emphasizes that emotional intelligence (EI) is crucial for effective leadership in the complex pharmaceutical industry, moving beyond the sole reliance on technical skills. It introduces Daniel Goleman's four key domains of EI: self-awareness, self-management, social awareness, and relationship management, explaining their relevance to pharmaceutical challenges. The document illustrates how applying these EI competencies can help leaders navigate common scenarios like launch failures, project reprioritization, and cross-functional conflicts, offering practical examples for each. Furthermore, it suggests various reflection tools and skill-building exercises to enhance emotional intelligence, arguing that EI provides a competitive advantage by fostering resilient teams, innovation, and psychological safety.